FDA Inspection
Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc. – FDA Inspection, Apr 25, 2018
Record Details
This FDA Inspection record concerns Alnylam Pharmaceuticals, Inc., with an inspection on April 25, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 416acd03-3f7b-46f1-a91a-64c29ee36158
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050979
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Alnylam Pharmaceuticals, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Alnylam Pharmaceuticals, Inc.
- FDA Inspection 1181120 - 2022-09-09
- FDA Inspection 1107254 - 2019-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.